-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FhDTKGi9nqY14TcLeDCGBLLHzQfpm7Y6nDyxwISNTy3vAfmk9sN7FriGvnXrfzkh oC51b1b6UG+xyrSp6kUrpA== 0000950130-97-004191.txt : 19970923 0000950130-97-004191.hdr.sgml : 19970923 ACCESSION NUMBER: 0000950130-97-004191 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970918 ITEM INFORMATION: FILED AS OF DATE: 19970922 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-10432 FILM NUMBER: 97683547 BUSINESS ADDRESS: STREET 1: MERIDIAN CENTRE II STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07724 BUSINESS PHONE: 9083891182 MAIL ADDRESS: STREET 1: MERIDIAN CTR II STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07724 8-K 1 FORM 8-K FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 1997 ROBERTS PHARMACEUTICAL CORPORATION - -------------------------------------------------------------------------------- (exact name of registrant as specified in its charter) NEW JERSEY 1-1-432 22-2429994 - ---------------------- ----------------- --------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification incorporation) Number) Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: 908-389-1182 Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Former name or former address, if changed from last report) -2- Item 5. Other Events ------------ Roberts Pharmaceutical Corporation today indicated that, as a result of several recent developments, the Company expects to report a net loss approximating $0.07 to $0.11 per share for the third quarter ending September 30, 1997. In addition to the one-time, pre tax charge of $1.8 million associated with the settlement of a shareholder class action lawsuit announced on July 31, new factors accounting for the revised outlook include: higher than expected legal expenses associated with the settlement; a decision to increase marketing expenditures in response to a specific product opportunity; delayed sales of certain products due to back orders with third-party manufacturers; and slower than expected wholesaler pull-through of ProAmatine/R/ and Agrylin/TM/. The Company stated that it has reported an operating profit for three consecutive quarters and given the non-recurring nature of a significant portion of the factors impacting the third quarter, the Company expects to resume profitability in the fourth quarter of the year. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROBERTS PHARMACEUTICAL CORPORATION ---------------------------------- (Registrant) Date: September 22, 1997 By: /s/ Anthony A. Rascio ------------------------------ Anthony A. Rascio Vice President -----END PRIVACY-ENHANCED MESSAGE-----